These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11479952)

  • 1. [Insulin resistance in patients with polycystic ovary syndrome].
    Wu J; Zhou S; Su Y
    Zhonghua Fu Chan Ke Za Zhi; 1999 Nov; 34(11):698-701. PubMed ID: 11479952
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin and polycystic ovary syndrome.
    Lebinger TG
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):132-40. PubMed ID: 17940431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of insulin and hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome].
    Vasiljević M
    Srp Arh Celok Lek; 2000; 128(9-10):335-9. PubMed ID: 11255689
    [No Abstract]   [Full Text] [Related]  

  • 4. Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.
    Carmassi F; De Negri F; Fioriti R; De Giorgi A; Giannarelli C; Fruzzetti F; Pedrinelli R; Dell'Omo G; Bersi C
    Thromb Res; 2005; 116(3):207-14. PubMed ID: 15935829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovary syndrome and insulin resistance.
    Plosker SM
    Med Health R I; 2003 Jan; 86(1):12-5. PubMed ID: 12633015
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metformin for the treatment of polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M
    Akush Ginekol (Sofiia); 2005; 44(4):37-41. PubMed ID: 16028378
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S69-73. PubMed ID: 19007650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The direct effect of insulin on the ovary and the pathogenesis of the polycystic ovary syndrome].
    Presl J
    Cesk Gynekol; 1984 Mar; 49(2):124-5. PubMed ID: 6368015
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiometabolic features of polycystic ovary syndrome.
    Hoffman LK; Ehrmann DA
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin resistance inpolycystic ovary syndrome].
    Castro-Acuña V; Martínez-Martínez L; del Carmen Cravioto M
    Rev Invest Clin; 2004; 56(6):763-72. PubMed ID: 15791913
    [No Abstract]   [Full Text] [Related]  

  • 11. Insulin-sensitizing agents in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insulin sensitizers in the treatment of polycystic ovary].
    Ortiz Núñez DA; Hernández Marín I; Ayala AR
    Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Expert Opin Ther Targets; 2009 Oct; 13(10):1205-26. PubMed ID: 19650762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Polycystic ovary syndrome and insulin resistance].
    Puder J; Pralong F
    Rev Med Suisse; 2009 Apr; 5(198):779-82. PubMed ID: 19418980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Kandaraki E; Christakou C; Panidis D
    Obes Rev; 2009 Jul; 10(4):431-41. PubMed ID: 19413702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of insulin in polycystic ovary syndrome].
    Sindelka G; Skrha J; Cibula D; Prázný M
    Cas Lek Cesk; 2002 Dec; 141(24):769-72. PubMed ID: 12661468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chromium supplementation on insulin resistance and ovarian and menstrual cyclicity in women with polycystic ovary syndrome.
    Lucidi RS; Thyer AC; Easton CA; Holden AE; Schenken RS; Brzyski RG
    Fertil Steril; 2005 Dec; 84(6):1755-7. PubMed ID: 16359984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: a pilot study.
    Wang JG; Anderson RA; Graham GM; Chu MC; Sauer MV; Guarnaccia MM; Lobo RA
    Fertil Steril; 2007 Jul; 88(1):240-3. PubMed ID: 17296187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis.
    Nader S; Diamanti-Kandarakis E
    Hum Reprod; 2007 Feb; 22(2):317-22. PubMed ID: 17099212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of long-term treatment with metformin on steroid levels and parameters of insulin resistance in women with polycystic ovary syndrome].
    Vrbíková J; Hill M; Stárka L; Cibula D; Snajderová M; Sulcová J; Vondra K; Bendlová B
    Cas Lek Cesk; 2001 Nov; 140(22):688-94. PubMed ID: 11789058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.